140 related articles for article (PubMed ID: 37024479)
1. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction.
Gong L; Luo J; Zhang Y; Yang Y; Li S; Fang X; Zhang B; Huang J; Chow LK; Chung D; Huang J; Huang C; Liu Q; Bai L; Tiu YC; Wu P; Wang Y; Tsao GS; Kwong DL; Lee AW; Dai W; Guan XY
Nat Commun; 2023 Apr; 14(1):1912. PubMed ID: 37024479
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Ujiie N; Kosaka A; Ohkuri T; Oikawa K; Sato R; Wakisaka R; Kono M; Yamaki H; Ohara K; Kumai T; Kishibe K; Katada A; Hayashi T; Kobayashi H
Cancer Sci; 2024 Apr; 115(4):1073-1084. PubMed ID: 38279834
[TBL] [Abstract][Full Text] [Related]
3. CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
Arroyo Hornero R; Georgiadis C; Hua P; Trzupek D; He LZ; Qasim W; Todd JA; Ferreira RC; Wood KJ; Issa F; Hester J
Commun Biol; 2020 Jul; 3(1):375. PubMed ID: 32665635
[TBL] [Abstract][Full Text] [Related]
4. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
[TBL] [Abstract][Full Text] [Related]
5. Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc.
Dadas O; Allen JD; Buchan SL; Kim J; Chan HTC; Mockridge CI; Duriez PJ; Rogel A; Crispin M; Al-Shamkhani A
Front Immunol; 2023; 14():1252274. PubMed ID: 37965342
[TBL] [Abstract][Full Text] [Related]
6. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.
Jaeger-Ruckstuhl CA; Lo Y; Fulton E; Waltner OG; Shabaneh TB; Simon S; Muthuraman PV; Correnti CE; Newsom OJ; Engstrom IA; Kanaan SB; Bhise SS; Peralta JMC; Ruff R; Price JP; Stull SM; Stevens AR; Bugos G; Kluesner MG; Voillet V; Muhunthan V; Morrish F; Olson JM; Gottardo R; Sarthy JF; Henikoff S; Sullivan LB; Furlan SN; Riddell SR
Immunity; 2024 Feb; 57(2):287-302.e12. PubMed ID: 38354704
[TBL] [Abstract][Full Text] [Related]
7. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency.
Ghosh S; Köstel Bal S; Edwards ESJ; Pillay B; Jiménez Heredia R; Erol Cipe F; Rao G; Salzer E; Zoghi S; Abolhassani H; Momen T; Gostick E; Price DA; Zhang Y; Oler AJ; Gonzaga-Jauregui C; Erman B; Metin A; Ilhan I; Haskologlu S; Islamoglu C; Baskin K; Ceylaner S; Yilmaz E; Unal E; Karakukcu M; Berghuis D; Cole T; Gupta AK; Hauck F; Kogler H; Hoepelman AIM; Baris S; Karakoc-Aydiner E; Ozen A; Kager L; Holzinger D; Paulussen M; Krüger R; Meisel R; Oommen PT; Morris E; Neven B; Worth A; van Montfrans J; Fraaij PLA; Choo S; Dogu F; Davies EG; Burns S; Dückers G; Becker RP; von Bernuth H; Latour S; Faraci M; Gattorno M; Su HC; Pan-Hammarström Q; Hammarström L; Lenardo MJ; Ma CS; Niehues T; Aghamohammadi A; Rezaei N; Ikinciogullari A; Tangye SG; Lankester AC; Boztug K
Blood; 2020 Dec; 136(23):2638-2655. PubMed ID: 32603431
[TBL] [Abstract][Full Text] [Related]
8. The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.
Li S; Chen D; Guo H; Liu D; Yang C; Zhang R; Wang T; Zhang F; Bai X; Yang Y; Sun N; Zhang W; Zhang L; Zhao G; Peng L; Tu X; Tian W
Front Oncol; 2023; 13():1240061. PubMed ID: 37849799
[TBL] [Abstract][Full Text] [Related]
9. CD70-induced differentiation of proinflammatory Th1/17/22/GM lymphocytes associated with disease progression and immune reconstitution during HIV infection.
Wang X; Wei Y; He Z; Wang D; Zhang L; Du J; Zhang M; Jiang M; Chen N; Deng M; Li B; Song C; Chen D; Liu H; Xiao J; Liang H; Zhao H; Kong Y
Emerg Microbes Infect; 2023 Dec; 12(2):2271068. PubMed ID: 37824079
[TBL] [Abstract][Full Text] [Related]
10. METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.
Ning J; Hou X; Hao J; Zhang W; Shi Y; Huang Y; Ruan X; Zheng X; Gao M
Cell Death Differ; 2023 Oct; 30(10):2265-2279. PubMed ID: 37648786
[TBL] [Abstract][Full Text] [Related]
11. Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution.
Liu Y; He S; Wang XL; Peng W; Chen QY; Chi DM; Chen JR; Han BW; Lin GW; Li YQ; Wang QY; Peng RJ; Wei PP; Guo X; Li B; Xia X; Mai HQ; Hu XD; Zhang Z; Zeng YX; Bei JX
Nat Commun; 2021 Feb; 12(1):741. PubMed ID: 33531485
[TBL] [Abstract][Full Text] [Related]
12. Prognostic marker CD27 and its micro-environmental in multiple myeloma.
Wang X; Luo K; Xu Q; Chi L; Guo Y; Jia C; Quan L
BMC Cancer; 2024 Mar; 24(1):352. PubMed ID: 38504180
[TBL] [Abstract][Full Text] [Related]
13. Balsas P, Veloza L, Clot G, et al. SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma. Blood. 2021;138(22):2202-2215.
Blood; 2023 Sep; 142(13):1173-1176. PubMed ID: 37768692
[No Abstract] [Full Text] [Related]
14. Re: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.
Jiang A; Liu Y; Lin A; Luo P; Wang L
Eur Urol; 2024 May; ():. PubMed ID: 38735819
[No Abstract] [Full Text] [Related]
15. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.
Lv J; Wei Y; Yin JH; Chen YP; Zhou GQ; Wei C; Liang XY; Zhang Y; Zhang CJ; He SW; He QM; Huang ZL; Guan JL; Shen JY; Li XM; Li JY; Li WF; Tang LL; Mao YP; Guo R; Sun R; Zheng YH; Zhou WW; Xiong KX; Wang SQ; Jin X; Liu N; Li GB; Kuang DM; Sun Y; Ma J
Nat Med; 2023 Jun; 29(6):1424-1436. PubMed ID: 37280275
[TBL] [Abstract][Full Text] [Related]
16. Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics.
Cheng J; Zhao Y; Hu H; Tang L; Zeng Y; Deng X; Ding S; Guo AY; Li Q; Zhu X
Cancer Immunol Immunother; 2023 Oct; 72(10):3163-3174. PubMed ID: 37382633
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review).
Huang H; Yao Y; Deng X; Huang Z; Chen Y; Wang Z; Hong H; Huang H; Lin T
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37417358
[TBL] [Abstract][Full Text] [Related]
18. The immune escape mechanism of nasopharyngeal carcinoma.
Li X; Guo Y; Xiao M; Zhang W
FASEB J; 2023 Jul; 37(7):e23055. PubMed ID: 37358482
[TBL] [Abstract][Full Text] [Related]
19. Spatial transcriptomics combined with single-cell RNA-sequencing unravels the complex inflammatory cell network in atopic dermatitis.
Mitamura Y; Reiger M; Kim J; Xiao Y; Zhakparov D; Tan G; Rückert B; Rinaldi AO; Baerenfaller K; Akdis M; Brüggen MC; Nadeau KC; Brunner PM; Roqueiro D; Traidl-Hoffmann C; Akdis CA
Allergy; 2023 Aug; 78(8):2215-2231. PubMed ID: 37312623
[TBL] [Abstract][Full Text] [Related]
20. Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
Juarez-Vignon Whaley JJ; Afkhami M; Sampath S; Amini A; Bell D; Villaflor VM
Curr Treat Options Oncol; 2023 Jul; 24(7):845-866. PubMed ID: 37145382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
